Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> LUNG CANCER Latest News

8 HOURS AGO - Yahoo! News

A Must Read - Share

AstraZeneca steps up push into cancer immunotherapy

By Ben Hirschler LONDON (Reuters) - AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types. The company is seen as No. 4 in a race to develop the first drug in a new class that fights cancer by unleashing the body's immune system, behind rivals Roche, Merck & Co ...

Tags: AstraZeneca steps up push into cancer immunotherapy,  Lung Cancer Latest News

15 HOURS AGO - Philadelphia Inquirer

A Must Read - Share

Richard Schmid, leader in company

Richard Schmid, 65, of Cinnaminson, a member of the board of directors of Pemberton Fabricators Inc. in Rancocas, died of lung cancer Saturday, July 26, at home.

Tags: Richard Schmid, leader in company,  Lung Cancer Latest News

22 HOURS AGO - Huffington Post

A Must Read - Share

What Your Hands Can Reveal About Your Health

SPECIAL FROM Grandparents.com You don’t have to go to a palm reader to learn about your future. Pay attention to the state of your mitts—your nails, skin, and fingers can indicate all kinds of conditions and issues all by themselves. Discoloration under the nail A brown or black streak under the nail could be acral melanoma, a skin cancer that ...

Tags: What Your Hands Can Reveal About Your Health,  Lung Cancer Latest News

JUL 30, 2014 - Futurity

A Must Read - Share

Can patients with cancer risk handle false positives?

Many people who undergo preventative computerized tomography (CT) lung screenings receive positive results on the screening test, only to find out that … Continued The post Can patients with cancer risk handle false positives? appeared first on Futurity.

Tags: Can patients with cancer risk handle false positives?,  Lung Cancer Latest News

JUL 30, 2014 - Yahoo! News

A Must Read - Share

AstraZeneca buys Almirall lung drugs for up to $2.1 billion

By Ben Hirschler LONDON (Reuters) - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs. The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer in May, said it would pay an initial $875 million ...

Tags: AstraZeneca buys Almirall lung drugs for up to $2.1 billion,  Lung Cancer Latest News